Search
Gain Therapeutics Inc
GANXAdd to Watchlist
1.880USD
+0.100+5.62%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
79.88MMarket Cap
LossP/E TTM
Gain Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-06-18The current valuation score of Gain Therapeutics Inc is 6.04, ranking 363 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -3.21, which is -77.71% below the recent high of -0.71 and -114.43% above the recent low of -6.87.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.
